Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Environ Int. 2020 Oct 27;146:106204. doi: 10.1016/j.envint.2020.106204

Figure 4.

Figure 4.

Violin plots (heavy horizontal line=median, dashed horizontal lines=quartiles) of (A) maternal body weight gain and (B) relative liver weight normalized to control, and (C) serum HFPO-DA concentration, and (D) liver HFPO-DA concentration across two dosing intervals, GD16–20 (white bars) and GD8–22 or PND2 (shaded bars). Data for 1 and 3 mg/kg/d exposure during GD16–20 interval not shown (no significant difference from control). Asterisks represent significant difference compared to respective interval control (*, p<0.05; **, p<0.01; ***, p<0.001; ****, p<0.0001). Hashes represent significant difference between intervals within a dose level (#, p<0.05; ##, p<0.01; ###, p<0.001; ####, p<0.0001).